Protective immunity against hepatitis C virus infection

Immunology and Cell Biology

Volumn 84, Issue 3, 2006, Pages 239-249

  Elliott, Lisa N ^a,b   Lloyd, Andrew R ^b   Ziegler, John B ^a   Ffrench, Rosemary A ^a,c  

^a School of Women's and Children's Health UNSW Australia   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BURNET INSTITUTE   (Australia)

Author keywords

Cellular immunity; Hepatitis C virus; Vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; VIRUS RNA;

ANTIBODY RESPONSE; ANTIBODY TITER; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG TARGETING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION CONTROL; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIBODY FORMATION; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNITY, CELLULAR; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VIRAL HEPATITIS VACCINES;

ALPHAVIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 33646119430     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2006.01427.x     Document Type: Review

References (143)

1. Fujinami RS Oldstone MB. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 1979 279 529 30.
2. Oldstone MB Fujinami RS Lampert PW. Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog. Med. Virol. 1980 26 45 93.
3. Reinhardt B Jaspert R Niedrig M Kostner C L'Age-Stehr J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J. Med. Virol. 1998 56 159 67.
4. Law M Smith GL. Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology 2001 280 132 42.
5. Flamand A Raux H Gaudin Y Ruigrok RW. Mechanisms of rabies virus neutralization. Virology 1993 194 302 13.
6. Pantaleo G Demarest JF Vaccarezza M et al. Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur. J. Immunol. 1995 25 226 31.
7. Burioni R Williamson RA Sanna PP Bloom FE Burton DR. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc. Natl Acad. Sci. USA 1994 91 355 9.
8. Burton DR Williamson RA Parren PW. Antibody and virus: binding and neutralization. Virology 2000 270 1 3.
9. Klasse PJ Sattentau QJ. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 2002 83 2091 108.
10. Alter H. Discovery of non-A, non-B hepatitis and identification of its etiology. Am. J. Med. 1999 107 16 20.
11. Gerlach JT Diepolder HM Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003 125 80 88.
12. Freeman AJ Marinos G Ffrench RA Lloyd AR. Immunopathogenesis of hepatitis C virus infection. Immunol. Cell Biol. 2001 79 515 36.
13. Thomas DL Astemborski J Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000 284 450 56.
14. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002 36 S35 S46.
15. Santantonio T Sinisi E Guastadisegni A et al. Natural course of acute hepatitis C: a long-term prospective study. Dig. Liver Dis. 2003 35 104 13.
16. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N. Engl. J. Med. 1999 340 1228 33.
17. Lai ME Mazzoleni AP Argiolu F et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994 343 388 90.
18. Farci P Alter HJ Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992 258 135 40.
19. Bassett SE Guerra B Brasky K et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 2001 33 1479 87.
20. Major ME Mihalik K Puig M et al. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J. Virol. 2002 76 6586 95.
21. Prince AM Brotman B Huima T Pascual D Jaffery M Inchauspe G. Immunity in hepatitis C infection. J. Infect. Dis. 1992 165 438 43.
22. Rowland-Jones S Sutton J Ariyoshi K et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1995 1 59 64.
23. Fowke KR Nagelkerke NJ Kimani J et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996 348 1347 51.
24. Bassett SE Brasky KM Lanford RE. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J. Virol. 1998 72 2589 99.
25. Pancholi P Lee DH Liu Q et al. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology 2001 33 448 54.
26. Kolykhalov AA Agapov EV Blight KJ Mihalik K Feinstone SM Rice CM. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997 277 570 74.
27. Chen M Sallberg M Sonnerborg A et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 1999 116 135 43.
28. Takaki A Wiese M Maertens G et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 2000 6 578 82.
29. Villano SA Vlahov D Nelson KE Cohn S Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999 29 908 14.
30. Abe K Inchauspe G Shikata T Prince AM. Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology 1992 15 690 95.
31. Farci P Shimoda A Wong D et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl Acad. Sci. USA 1996 93 15 394 9.
32. Mehta SH Cox A Hoover DR et al. Protection against persistence of hepatitis C. Lancet 2002 359 1478 83.
33. Bjoro K Froland SS Yun Z Samdal HH Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N. Engl. J. Med. 1994 331 1607 11.
34. Razvi S Schneider L Jonas MM Cunningham-Rundles C. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin. Immunol. 2001 101 284 8.
35. Chapel HM Christie JM Peach V Chapman RW. Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin. Immunol. 2001 99 320 24.
36. Kobayashi M Tanaka E Matsumoto A Ichijo T Kiyosawa K. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. J. Gastroenterol. Hepatol. 1997 12 73 6.
37. Grellier L Brown D Power J Dusheiko G. Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977. J. Viral Hepat. 1997 4 379 81.
38. Logvinoff C Major ME Oldach D et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl Acad. Sci. USA 2004 101 10 149 54.
39. Yu MY Bartosch B Zhang P et al. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc. Natl Acad. Sci. USA 2004 101 7705 710.
40. Farci P Alter HJ Wong DC et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl Acad. Sci. USA 1994 91 7792 6.
41. Bartosch B Bukh J Meunier JC et al. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl Acad. Sci. USA 2003 100 14 199 204.
42. Lavillette D Morice Y Germanidis G et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J. Virol. 2005 79 6023 34.
43. Scarselli E Cerino A Esposito G Silini E Mondelli MU Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J. Virol. 1995 69 4407 12.
44. Shimizu YK Hijikata M Iwamoto A Alter HJ Purcell RH Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 1994 68 1494 500.
45. Lechner F Wong DK Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000 191 1499 512.
46. Thimme R Bukh J Spangenberg HC et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl Acad. Sci. USA 2002 99 15 661 8.
47. Gerlach JT Diepolder HM Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 933 41.
48. Wertheimer AM Miner C Lewinsohn DM Sasaki AW Kaufman E Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 2003 37 577 89.
49. Lauer GM Barnes E Lucas M et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 2004 127 924 36.
50. Chang KM Thimme R Melpolder JJ et al. Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection. Hepatology 2001 33 267 76.
51. Tsai SL Liaw YF Chen MH Huang CY Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997 25 449 58.
52. Diepolder HM Zachoval R Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 1006 1007.
53. Cooper S Erickson AL Adams EJ et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999 10 439 49.
54. Gruner NH Gerlach TJ Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis. 2000 181 1528 36.
55. Cucchiarini M Kammer AR Grabschield B et al. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell. Immunol. 2000 203 111 23.
56. Nelson DR Marousis CG Davis GL et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 1997 158 1473 81.
57. Freeman AJ Pan Y Harvey CE et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 2003 38 349 56.
58. Shoukry NH Grakoui A Houghton M et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 2003 197 1645 55.
59. Thimme R Oldach D Chang KM Steiger C Ray SC Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001 194 1395 406.
60. Ulsenheimer A Gerlach JT Gruener NH et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003 37 1189 98.
61. Gruener NH Lechner F Jung MC et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 2001 75 5550 58.
62. Thursz M Yallop R Goldin R Trepo C Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 1999 354 2119 24.
63. Cramp ME Carucci P Underhill J Naoumov NV Williams R Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 1998 29 207 13.
64. Zavaglia C Martinetti M Silini E et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J. Hepatol. 1998 28 1 7.
65. Harcourt G Hellier S Bunce M et al. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J. Viral Hepat. 2001 8 174 9.
66. Chang KM Rehermann B McHutchison JG et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 1997 100 2376 85.
67. Nascimbeni M Mizukoshi E Bosmann M et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J. Virol. 2003 77 4781 93.
68. Grakoui A Shoukry NH Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 659 62.
69. Micallef JM Jauncey M Amin J et al. Hepatitis C virus re-infection within a cohort of injecting drug users. Hepatology 2003 38 266A.
70. Wiese M Berr F Lafrenz M Porst H Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000 32 91 6.
71. George SL Gebhardt J Klinzman D et al. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J. Acquir. Immune Defic. Syndr. 2002 31 154 62.
72. Thio CL Nolt KR Astemborski J Vlahov D Nelson KE Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 2000 38 575 7.
73. Rossi G Tucci A Cariani E Ravaggi A Rossini A Radaeli E. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997 90 1309 14.
74. Bronowicki JP Vetter D Uhl G et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J. Infect. Dis. 1997 176 518 22.
75. Koziel MJ Wong DK Dudley D Houghton M Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J. Infect. Dis. 1997 176 859 66.
76. Scognamiglio P Accapezzato D Casciaro MA et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 1999 162 6681 9.
77. Freeman AJ Ffrench RA Post JJ et al. Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J. Infect. Dis. 2004 190 1093 7.
78. Post JJ Pan Y Freeman AJ et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis. 2004 189 1846 55.
79. Kamal SM Amin A Madwar M et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J. Virol. 2004 78 12 252 8.
80. Della Bella S Riva A Tanzi E et al. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women. J. Hepatol. 2005 43 394 402.
81. Al-Sherbiny M Osman A Mohamed N et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am. J. Trop. Med. Hyg. 2005 73 44 9.
82. Crofts N Jolley D Kaldor J van Beek I Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J. Epidemiol. Community Health 1997 51 692 7.
83. Villano SA Vlahov D Nelson KE Lyles CM Cohn S Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore Maryland. J. Clin. Microbiol. 1997 35 3274 7.
84. van Beek I Dwyer R Dore GJ Luo K Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998 317 433 7.
85. Thomas DL Vlahov D Solomon L et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995 74 212 20.
86. Wong DK Dudley DD Dohrenwend PB et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J. Virol. 2001 75 1229 35.
87. Shata MT Tricoche N Perkus M et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 2003 314 601 16.
88. Cai Z Sprent J. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro. J. Exp. Med. 1996 183 2247 57.
89. Rees W Bender J Teague TK et al. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl Acad. Sci. USA 1999 96 9781 6.
90. Oh S Hodge JW Ahlers JD Burke DS Schlom J Berzofsky JA. Selective induction of high avidity CTL by altering the balance of signals from APC. J. Immunol. 2003 170 2523 30.
91. Gallimore A Dumrese T Hengartner H Zinkernagel RM Rammensee HG. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 1998 187 1647 57.
92. Slifka MK Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2001 2 711 17.
93. Derby M Alexander-Miller M Tse R Berzofsky J. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 2001 166 1690 97.
94. Beld M Penning M van Putten M et al. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 1999 94 1183 91.
95. Durand F Danic B Tardivel R et al. Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months. Transfus. Clin. Biol. 2000 7 242 50.
96. Durand F Beauplet A Marcellin P. Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donor. Ann. Intern. Med. 2000 133 74 5.
97. Peoples BG Preston SB Tzeng JL Stramer SL Gifford L Wissel ME. Prolonged antibody-negative HCV viremia in a US blood donor with apparent HCV transmission to a recipient. Transfusion (Paris) 2000 40 1280 81.
98. Clerici M Sison AV Berzofsky JA et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993 7 1427 33.
99. Clerici M Levin JM Kessler HA et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994 271 42 6.
100. Langlade-Demoyen P Ngo-Giang-Huong N Ferchal F Oksenhendler E. Human immunodeficiency virus (HIV) Nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 1994 93 1293 7.
101. Rowland-Jones SL McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 1995 7 448 55.
102. Fowke KR Kaul R Rosenthal KL et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol. Cell Biol. 2000 78 586 95.
103. Clerici M Giorgi JV Chou CC et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 1992 165 1012 19.
104. Pinto LA Sullivan J Berzofsky JA et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 1995 96 867 76.
105. MacDonald KS Embree J Njenga S et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J. Infect. Dis. 1998 177 551 6.
106. MacDonald KS Fowke KR Kimani J et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J. Infect. Dis. 2000 181 1581 9.
107. Rowland-Jones SL Nixon DF Aldhous MC et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993 341 860 61.
108. Rowland-Jones SL Dong T Fowke KR et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 1998 102 1758 65.
109. Kaul R Rowland-Jones SL Kimani J et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol. Lett. 2001 79 3 13.
110. Mazzoli S Trabattoni D Lo Caputo S et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 1997 3 1250 57.
111. Kaul R Trabattoni D Bwayo JJ et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999 13 23 9.
112. Jennes W Sawadogo S Koblavi-Deme S et al. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Cote d'Ivoire. J. Infect. Dis. 2003 187 206 14.
113. Alvarez V Lopez-Larrea C Coto E. Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users. Hum. Genet. 1998 102 483 6.
114. Plummer FA Ball TB Kimani J Fowke KR. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol. Lett. 1999 66 27 34.
115. Zhu T Corey L Hwangbo Y et al. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J. Virol. 2003 77 6108 16.
116. Kaul R Rowland-Jones SL Kimani J et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J. Clin. Invest. 2001 107 341 9.
117. Murphey-Corb M Wilson LA Trichel AM et al. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 1999 162 540 49.
118. Belyakov IM Ahlers JD Brandwein BY et al. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 1998 102 2072 81.
119. Selin LK Nahill SR Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 1994 179 1933 43.
120. Selin LK Varga SM Wong IC Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 1998 188 1705 15.
121. Selin LK Lin MY Kraemer KA et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 1999 11 733 42.
122. Wedemeyer H Mizukoshi E Davis AR Bennink JR Rehermann B. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 2001 75 11 392 400.
123. Urbani S Amadei B Fisicaro P et al. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 2005 201 675 80.
124. Lauer GM Ouchi K Chung RT et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 2002 76 6104 13.
125. Albert ML Sauter B Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998 392 86 9.
126. Ogata N Alter HJ Miller RH Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl Acad. Sci. USA 1991 88 3392 6.
127. Nowak M. HIV mutation rate. Nature 1990 347 522.
128. Zinkernagel RM Bachmann MF Kundig TM Oehen S Pirchet H Hengartner H. On immunological memory. Annu. Rev. Immunol. 1996 14 333 67.
129. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 1994 179 317 21.
130. Lau LL Jamieson BD Somasundaram T Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994 369 648 52.
131. Veiga-Fernandes H Walter U Bourgeois C McLean A Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat. Immunol. 2000 1 47 53.
132. Zinkernagel RM. On differences between immunity and immunological memory. Curr. Opin. Immunol. 2002 14 523 36.
133. Bronowicki JP Loriot MA Thiers V Grignon Y Zignego AL Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 1998 28 211 18.
134. Laporte J Bain C Maurel P Inchauspe G Agut H Cahour A. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2003 101 52 7.
135. Crovatto M Pozzato G Zorat F et al. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 2000 85 356 61.
136. Sansonno D Lotesoriere C Cornacchiulo V et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998 92 3328 37.
137. Laskus T Radkowski M Bednarska A et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 2002 76 10 064 8.
138. Radkowski M Wilkinson J Nowicki M et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 2002 76 600 608.
139. Laskus T Radkowski M Wang LF Vargas H Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998 28 1398 401.
140. Laskus T Radkowski M Wang LF Jang SJ Vargas H Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 1998 248 164 71.
141. Laskus T Radkowski M Wang LF Nowicki M Rakela J. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J. Virol. 2000 74 1014 17.
142. Pham TN MacParland SA Mulrooney PM Cooksley H Naoumov NV Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 2004 78 5867 74.
143. Radkowski M Gallegos-Orozco JF Jablonska J et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005 41 106 14.